BEVACIZUMAB
DrugBank ID: db00112
DrugCentral: bevacizumab
Synonymous :anti-vegf humanized monoclonal antibody | anti-vegf monoclonal antibody | bevacizumab | bevacizumab-awwb | rhumab-vegf
Drug Sentece Context
Table 1. Analysis of context sentence of bevacizumab gene in 8 abstracts.
| pmid | sentence |
|---|---|
| 32256547 | We identified 24 clinical trials, involving more than 20 medicines, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, methylprednisolone, bevacizumab, and traditional Chinese medicines (TCM). […] Se identificaron 24 ensayos clínicos relacionados con más de 20 medicamentos, como inmunoglobulina humana, interferones, cloroquina, hidroxicloroquina, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, metilprednisolona, bevacizumab y medicina tradicional china. |
| 32397911 | In particular, hydroxychloroquine, remdesivir, favipiravir, arbidol, tocilizumab and bevacizumab have shown promising results. |
| 32549297 | This review also reports the rationale for a possible use of drugs commonly employed in neoplastic therapy, such as bevacizumab, ibrutinib, selinexor, thalidomide, carfilzomib, and PD-1 inhibitors, for the treatment of SARS-CoV-2 infection. |
| 32568969 | These therapies include immunomodulators (i.e. intravenous immunoglobulin, thymosin α-1, IL-6, tocilizumab, cyclosporine, thalidomide, fingolimod), Chinese medicines (i.e. glycyrrhizin, baicalin, Xuebijing), anti-vascular endothelial growth factors (bevacizumab), estrogen modulating drugs, statins and nutritional supplements (i.e. vitamin A, B, C, D, E and zinc). |
| 32682788 | Several drugs such as Remdesivir, Hydroxychloroquine, Chloroquine, Ribavirin, Ritonavir, Lopinavir, Favipiravir, Interferons, Bevacizumab, Azithromycin, etc. are currently under clinical trials. |
| 33511068 | The patients received two immune modulators (tocilizumab and bevacizumab) in different combinations to retrieve broader insights about the safety and efficacy of immune modulators in COVID-19 management. […] On the other hand, a dramatic survival benefit was found in patients receiving bevacizumab (92%). |
| 33519272 | Five drugs Azithromycin, Bevacizumab, CQ, HCQ, and Lopinavir, are retrieved. |
| 33547300 | Relative to comparable controls, bevacizumab shows clinical efficacy by improving oxygenation and shortening oxygen-support duration. […] Our findings suggest bevacizumab plus standard care is highly beneficial for patients with severe Covid-19. |